Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Final results of a phase III trial
第一作者机构:[1]Sun Yat Sen Univ, Colorectal Surg, Canc Ctr, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
Ding P. R.,Wang X. Z.,Li Y-F.,et al.Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Final results of a phase III trial[J].ANNALS OF ONCOLOGY.2023,34:S1267-S1268.doi:10.1016/j.annonc.2023.10.018.
APA:
Ding, P. R.,Wang, X. Z.,Li, Y-F.,Sun, Y. M.,Yang, C-K....&Wan, D. S..(2023).Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Final results of a phase III trial.ANNALS OF ONCOLOGY,34,
MLA:
Ding, P. R.,et al."Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Final results of a phase III trial".ANNALS OF ONCOLOGY 34.(2023):S1267-S1268